AU2023901051A0 - Methods for the identification and treatment of chronic kidney disease - Google Patents

Methods for the identification and treatment of chronic kidney disease

Info

Publication number
AU2023901051A0
AU2023901051A0 AU2023901051A AU2023901051A AU2023901051A0 AU 2023901051 A0 AU2023901051 A0 AU 2023901051A0 AU 2023901051 A AU2023901051 A AU 2023901051A AU 2023901051 A AU2023901051 A AU 2023901051A AU 2023901051 A0 AU2023901051 A0 AU 2023901051A0
Authority
AU
Australia
Prior art keywords
identification
treatment
methods
kidney disease
chronic kidney
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023901051A
Inventor
Ewa GOLDYS
Abbas Habibalahi
Sabbah Mahbub
Carol Pollock
Sonia Saad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sydney
NewSouth Innovations Pty Ltd
Original Assignee
University of Sydney
NewSouth Innovations Pty Ltd
Filing date
Publication date
Application filed by University of Sydney, NewSouth Innovations Pty Ltd filed Critical University of Sydney
Publication of AU2023901051A0 publication Critical patent/AU2023901051A0/en
Pending legal-status Critical Current

Links

AU2023901051A 2023-04-11 Methods for the identification and treatment of chronic kidney disease Pending AU2023901051A0 (en)

Publications (1)

Publication Number Publication Date
AU2023901051A0 true AU2023901051A0 (en) 2023-04-27

Family

ID=

Similar Documents

Publication Publication Date Title
EP3999548A4 (en) Claudin18 antibodies and methods of treating cancer
EP3886981A4 (en) Systems and methods for enhancing efficacy of ultrasound treatment
EP3969125A4 (en) Use of anti-fcrn antibodies in the treatment of pemphighus and pemphigoid diseases
EP4138694A4 (en) Methods and systems for venous disease treatment
EP3930742A4 (en) Whole blood treatment device and methods of removing target agents from whole blood
AU2023901051A0 (en) Methods for the identification and treatment of chronic kidney disease
AU2022900913A0 (en) Methods for the identification and treatment of chronic kidney disease
AU2021901061A0 (en) Methods for the identification and treatment of chronic kidney disease
EP4017490A4 (en) Compounds and methods for treating oxalate-related diseases
EP3938364A4 (en) Compounds for and methods of treating diseases
EP4026562A4 (en) Chronic kidney disease treatment or prevention method
AU2021901144A0 (en) Methods for the identification and treatment of chronic kidney disease using cell morphology
AU2023901048A0 (en) Methods for the identification and treatment of chronic kidney disease using cell morphology
AU2022900914A0 (en) Methods for the identification and treatment of chronic kidney disease using cell morphology
AU2022231043A1 (en) Chaperonin-containing tcp-1 inhibitors for the treatment of cancer
TWI799923B (en) Use of thioimidazolidinone drugs in the treatment of covid-19 disease
EP3448378A4 (en) Pla2 and hmg-coa inhibitors for treatment of pathological conditions causing hemolysis, cerebral edema, and acute kidney injury
AU2021305983B2 (en) Combination of zibotentan and dapagliflozin for the treatment of chronic kidney disease
WO2020186111A3 (en) Vista-binding antibodies and uses thereof
AU2022426744A1 (en) Compositions and methods for diagnosing and treating chronic kidney disease
EP3769762A4 (en) Drug and method for treating or preventing kidney disease using said drug
AU2023901981A0 (en) Antibody-Drug-Conjugates And Uses Thereof For The Treatment of Cancer
AU2022901708A0 (en) Antibody-Drug-Conjugates And Uses Thereof For The Treatment of Cancer
PH12021551005A1 (en) Methods of Treating Chronic Kidney Disease with Dapagliflozin
IL282665A (en) Methods of treating chronic kidney disease with dapagliflozin